ClinicalTrials.govpublic full text
A Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Treated 7-Day Stored Apheresis Platelet Components in 35% Plasma and 65% InterSol and 7-Day Stored Apheresis Platelet Components in 100% Plasma
healthy, intercept, platelet, pathogen inactivation, platelet components stored, therapeutic efficacy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 902974
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.